GoodRx Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 12, 2021, announces the financial results for GoodRx Holdings, Inc. for the three and six months ended June 30, 2021. The Company is an emerging growth company incorporated in Delaware, with its Class A Common Stock (GDRX) trading on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release and letter to shareholders furnished as Exhibits 99.1 and 99.2, which are not included in the provided text.
Material Changes
No specific material changes versus prior periods are detailed in the body of this Form 8-K. The report serves as a notification that the results have been announced and directs readers to the attached exhibits for comparative data.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not explicitly detailed in the filing text. The report states that the full text of the press release and letter to shareholders, which would contain this information, are furnished as Exhibits 99.1 and 99.2.
Important Facts for Investors to Verify
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the periods ended June 30, 2021.
- Examine Exhibit 99.2 (Letter to Shareholders) for management's discussion of financial condition, strategic outlook, and risk factors.
- Note that the information in Item 2.02 and the exhibits is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Verify the Company's status as an emerging growth company and any associated election regarding extended transition periods for accounting standards.